Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: A missing link between CVD risk and obesity?

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages

  Pivovarova, Olga ^a,b   Gögebakan, Özlem ^a,b   Klöting, Nora ^c   Sparwasser, Andrea ^d   Weickert, Martin O ^a,b,e,f   Haddad, Isam ^g   Nikiforova, Victoria J ^h,i   Bergmann, Andreas ^d,j   Kruse, Michael ^a,b   Seltmann, Anne Cathrin ^a,b   Blüher, Matthias ^c   Pfeiffer, Andreas F H ^a,b   Rudovich, Natalia ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d THERMO FISHER SCIENTIFIC   (Germany)

^e UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g Metabolomic Discoveries GmbH   (Germany)

^h MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

ⁱ Metanomics Health GmbH   (Germany)

^j SPHINGOTEC GMBH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NATRIURETIC PEPTIDE RECEPTOR C;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; HYPERINSULINEMIA; INTRAABDOMINAL FAT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NPRA GENE; NPRB GENE; NPRC GENE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; UPREGULATION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; OBESITY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SUBCUTANEOUS FAT;

EID: 84860757691     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2839     Document Type: Article

References (35)

1. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM 2007 Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49:403-414
2. Kenchaiah S, Gaziano JM, Vasan RS 2004 Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am 88:1273-1294
3. McGrath MF, de Bold ML, de Bold AJ 2005 The endocrine function of the heart. Trends Endocrinol Metab 16:469-477
4. Potter LR, Abbey-Hosch S, Dickey DM 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47-72
5. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O 1999 The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96:7403-7408
6. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J 2008 Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19:130-137
7. Kiemer AK, Vollmar AM 2001 The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann Rheum Dis 60(Suppl 3):iii68-iii70
8. Ruskoaho H 2003 Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24:341-356
9. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A 2008 Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 26:831-843
10. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS 2004 Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594-600
11. Dessì-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A 1997 Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 15:1695-1699
12. Nakatsuji H, Maeda N, Hibuse T, Hiuge A, Hirata A, Kuroda Y, Kishida K, Kihara S, Funahashi T, Shimomura I 2010 Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem Biophys Res Commun 392:100-105
13. Reaven GM 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607
14. Blüher M, Bashan N, Shai I, Harman-Boehm I, Tarnovscki T, Avinaoch E, Stumvoll M, Dietrich A, Klöting N, Rudich A 2009 Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity. J Clin Endocrinol Metab 94:2507-2515
15. 2003 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5-S20
16. Moser M 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Do these differ from the U. S. recommendations? Which guidelines should the practicing physician follow? J Clin Hypertens (Greenwich) 1:48-54
17. De Fronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
18. Morgenthaler NG, Struck J, Thomas B, Bergmann A 2004 Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234-236
19. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH 2004 Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (mycobacteria. Proc Natl Acad Sci USA 101:4560-4565
20. Nikiforova VJ, Daub CO, Hesse H, Willmitzer L, Hoefgen R 2005 Integrative gene-metabolite network with implemented causality deciphers informational fluxes of sulphur stress response. J Exp Bot 56:1887-1896
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
22. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K 2009 Natriuretic peptides/cGMP/cGMP- dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58:2880-2892
23. Sarzani R, Paci VM, Zingaretti CM, Pierleoni C, Cinti S, Cola G, Rappelli A, Dessì-Fulgheri P 1995 Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. J Hypertens 13:1241-1246
24. Viguerie N, Vidal H, Arner P, Holst C, Verdich C, Avizou S, Astrup A, Saris WH, Macdonald IA, Klimcakova E, Clement K, Martinez A, Hoffstedt J, Sørensen TI, Langin D 2005 Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 48:123-131
25. Sarzani R, Marcucci P, Salvi F, Bordicchia M, Espinosa E, Mucci L, Lorenzetti B, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Rappelli A 2008 Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth. Int J Obes (Lond) 32:259-267
26. Miller JA, Abouchacra S, Zinman B, Skorecki KL, Logan AG 1993 Atrial natriuretic factor counteracts sodium-retaining actions of insulin in normal men. Am J Physiol 265:R584-R590
27. Moro C, Polak J, Richterova B, Sengenes C, Pelikanova T, Galitzky J, Stich V, Lafontan M, Berlan M 2005 Differential regulation of atrial natriuretic peptide-and adrenergic receptor-dependent lipolytic pathways in human adipose tissue. Metabolism 54:122-131
28. Melo LG, Steinhelper ME, Pang SC, Tse Y, Ackermann U 2000 ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 3:45-58
29. Clark BA, Sclater A, Epstein FH, Elahi D 1993 Effect of glucose, insulin, and hypertonicity on atrial natriuretic peptide levels in man. Metabolism 42:224-228
30. Bohlen L, Ferrari P, Papiri M, Allemann Y, Shaw S, Wiedmann P 1994 Atrial natriuretic factor increases in response to an acute glucose load. J Hypertens 12:803-807
31. Baba T, Heinemann L, Berger M, Sawicki PT 1995 Effect of 4-hour hyperglycaemia and hyperinsulinaemia on plasma atrial natriuretic factor concentrations. Horm Metab Res 27:95-99
32. Tanabe A, Naruse M, Wasada T, Naruse K, Yoshimoto T, Omori Y, Demura H 1995 Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations. Eur J Endocrinol 132:693-698
33. Clerico A, Del Ry S, Giannessi D 2000 Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 46:1529-1534
34. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ 2009 Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49-57
35. Khaleghi M, Al-Omari MA, Kondragunta V, Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Kullo IJ 2009 Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension. Am J Cardiol 103:1255-1260